Cargando…

Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis

BACKGROUND: Interleukin 2 (IL-2) is a cytokine secreted by activated T cells. Studies exploring recombinant human interleukin 2 (rhuIL-2) as an adjunctive immunotherapeutic agent to treat tuberculosis (TB) have shown variable results; however, the true therapeutic efficacy of rhuIL-2 administration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ruimei, Xi, Xiangyu, Wang, Chunying, Pan, Yong, Ge, Changhua, Zhang, Liying, Zhang, Shuo, Liu, Huimei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053227/ https://www.ncbi.nlm.nih.gov/pubmed/30024982 http://dx.doi.org/10.1371/journal.pone.0201025

Ejemplares similares

The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis
por: Shen, Hong, et al.
Publicado: (2015)

Efficacy and Safety of Adjunctive Recombinant Human Interleukin-2 for Patients with Pulmonary Tuberculosis: A Meta-Analysis
por: Sheng, Lina, et al.
Publicado: (2022)

Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis
por: Singh, Dhiraj Kumar, et al.
Publicado: (2021)

In vivo application of recombinant interleukin 2 in the immunotherapy of established cytomegalovirus infection
Publicado: (1987)

Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung
por: Gupta, Ankan, et al.
Publicado: (2012)

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.
por: Baars, J. W., et al.
Publicado: (1992)

Advances in adjunct therapy against tuberculosis: Deciphering the emerging role of phytochemicals
por: Fatima, Samreen, et al.
Publicado: (2021)

Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice
por: Chauhan, Priyanka, et al.
Publicado: (2013)

Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis
por: Ahidjo, Bintou Ahmadou, et al.
Publicado: (2016)

Arginine Adjunctive Therapy in Active Tuberculosis
por: Farazi, Aliasghar, et al.
Publicado: (2015)

Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis
por: Debnath, P. K., et al.
Publicado: (2012)

Modifying tumor-associated macrophages: An important adjunct to immunotherapy
por: Fridlender, Zvi G, et al.
Publicado: (2013)

Evaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy
por: Sekhon, Bhagwant Kaur, et al.
Publicado: (2016)

Patient Susceptibility to Candidiasis—A Potential for Adjunctive Immunotherapy
por: Davidson, Linda, et al.
Publicado: (2018)

Interleukin‐2 as an adjunct to antiretroviral therapy for HIV‐positive adults
por: Onwumeh, Jennifer, et al.
Publicado: (2017)

The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review
por: Lee, Chiyun, et al.
Publicado: (2021)

Small extracellular vesicles induce resistance to anti-GD2 immunotherapy unveiling tipifarnib as an adjunct to neuroblastoma immunotherapy
por: Liu, Xiaoming, et al.
Publicado: (2022)

N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis
por: Ejigu, Dawit A., et al.
Publicado: (2020)

Adjunctive corticosteroid therapy in patients with pulmonary tuberculosis
por: Lemos, Carolina Xavier, et al.
Publicado: (2022)

In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses.
por: Deehan, D. J., et al.
Publicado: (1994)

The Role of the Level of Interleukin-33 in the Therapeutic Outcomes of Immunotherapy in Patients with Allergic Rhinitis
por: Nasr, Wail Fayez, et al.
Publicado: (2018)

Specific and nonspecific immunotherapy as an adjunct to curative surgery for cancer of the lung.
por: Hollinshead, A. C., et al.
Publicado: (1981)

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
por: Bonam, Srinivasa Reddy, et al.
Publicado: (2020)

Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient
por: Martin, Jeremiah T., et al.
Publicado: (2009)

Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TB
por: Butov, Dmitry A, et al.
Publicado: (2011)

Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma
por: Zhang, Yake, et al.
Publicado: (2021)

Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis
por: Maiga, Mamoudou, et al.
Publicado: (2015)

The Research Progress in Immunotherapy of Tuberculosis
por: Mi, Jie, et al.
Publicado: (2021)

An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis
por: Karanika, Styliani, et al.
Publicado: (2022)

Interleukins in the treatment of melanoma
por: Xu, Xinyuan, et al.
Publicado: (2022)

Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer
por: Smith, Sean G., et al.
Publicado: (2016)

Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.
por: Pession, A., et al.
Publicado: (1998)

Localized Interleukin-12 for Cancer Immunotherapy
por: Nguyen, Khue G., et al.
Publicado: (2020)

The application of Interleukin-2 family cytokines in tumor immunotherapy research
por: Zhou, Yangyihua, et al.
Publicado: (2023)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

Immunotherapy: an alternative promising therapeutic approach against cancers
por: Gupta, Sneh Lata, et al.
Publicado: (2022)

Suppress for Success: A JAK Inhibitor for Adjunct Therapy of Tuberculosis
por: Dorhoi, Anca
Publicado: (2015)

Mycobacterium tuberculosis-Associated Necrotizing Pneumonia With Adjunctive Corticosteroid Therapy
por: Nguyen, Ho Lam, et al.
Publicado: (2019)

Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series
por: Delsing, Corine E, et al.
Publicado: (2014)

Functional Immune Reconstitution by Interleukin-2 Adjunctive Therapy for HIV/Mycobacterial Co-infection
por: Heyckendorf, Jan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_e99ubskufr6457t43a24f7uf9v